Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.

Nocentini G, Barzi A

Department of Experimental Medicine and Biochemical Science, University of Perugia.

Pharmacol Res. 1990 Sep-Oct;22 Suppl 1:39-40. doi: 10.1016/1043-6618(90)90797-h.

Abstract

摘要

相似文献

Pharmacol Res. 1990 Sep-Oct;22 Suppl 1:39-40. doi: 10.1016/1043-6618(90)90797-h.

Cancer Chemother Pharmacol. 1990;26(5):345-51. doi: 10.1007/BF02897291.

Gen Pharmacol. 1997 Nov;29(5):701-6. doi: 10.1016/s0306-3623(97)00011-6.

Anticancer Drugs. 1990 Dec;1(2):171-7. doi: 10.1097/00001813-199012000-00009.

Cancer Res. 1993 Jan 1;53(1):19-26.

Anticancer Res. 1986 Mar-Apr;6(2):329-33.

Biochem Pharmacol. 1996 Jul 12;52(1):65-71. doi: 10.1016/0006-2952(96)00139-6.

Adv Enzyme Regul. 1980;19:139-50. doi: 10.1016/0065-2571(81)90013-3.

Cancer Treat Rep. 1984 Oct;68(10):1293-4.

Cancer J. 2003 Jul-Aug;9(4):247-50. doi: 10.1097/00130404-200307000-00006.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。